Health Catalyst
HCAT
109 hedge funds and large institutions have $709M invested in Health Catalyst in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 49 increasing their positions, 14 reducing their positions, and 12 closing their positions.
2,206% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $78K
250% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 14
192% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 12
24% more funds holding
Funds holding: 88 → 109 (+21)
8.45% more ownership
Funds ownership: 64.28% → 72.74% (+8.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
13% less capital invested
Capital invested by funds: $811M → $709M (-$103M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$31.6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$31.2M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$28.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.4M |
| 5 |
ClearBridge Investments
New York
|
+$16.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$94.4M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$23.8M |
| 3 |
NVPX
Norwest Venture Partners XI
Palo Alto,
California
|
-$18.3M |
| 4 |
NVPX
Norwest Venture Partners XII
Palo Alto,
California
|
-$18.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$11.4M |
HCAT Hedge Fund Activity: Q1 2020 in Review
109 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q1 2020, worth a combined $709M — down 13% from $811M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new HCAT positions and 12 closed out — a net gain of 23 holders — while 49 added to existing stakes and 14 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $31.6M. The largest seller was SC US (TTGP), cutting an estimated $94.4M.
- 109 institutional investors held Health Catalyst (HCAT) as of Q1 2020, up from 88 in Q4 2019.
- Funds reported $709M of Health Catalyst stock for Q1 2020, down 13% quarter-over-quarter.
- 35 funds opened new Health Catalyst positions in Q1 2020 and 12 closed out, a net change of +23 holders.
- The largest Health Catalyst buyer in Q1 2020 was Janus Henderson Group, an estimated $31.6M added.
- The largest Health Catalyst seller in Q1 2020 was SC US (TTGP), an estimated $94.4M sold.
Based on aggregated 13F filings for Q1 2020.